Available to sourceHuman Prescription DrugGastrointestinal

Sodium Chloride

3 g/100mL · Injection Solution

By Fresenius Kabi USA, LLC

NDC: 63323-530
Route: Intravenous
Therapeutic class: Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative
Marketing category: ANDA

Package sizes

20 BAG in 1 CASE (63323-530-75) / 500 mL in 1 BAG (63323-530-21)NDC 63323-530-75Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.